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Thrombin-induced platelet microbial protein 1 (tPMP-1), a cationic antimicrobial polypeptide released
from thrombin-stimulated rabbit platelets, targets the Staphylococcus aureus cytoplasmic membrane to
initiate its microbicidal effects. In vitro resistance to tPMP-1 correlates with survival advantages in vivo.
In S. aureus, the plasmid-carried qacA gene encodes a multidrug transporter, conferring resistance to
organic cations (e.g., ethidium [Et]) via proton motive force (PMF)-energized export. We previously
showed that qacA also confers a tPMP-1-resistant (tPMP-1r) phenotype in vitro. The current study
evaluated whether (i) transporters encoded by the qacB and qacC multidrug resistance genes also confer
tPMP-1r and (ii) tPMP-1r mediated by qacA is dependent on efflux pump activity. In contrast to tPMP-1r
qacA-bearing strains, the parental strain and its isogenic qacB- and qacC-containing strains were tPMP-1
susceptible (tPMP-1s). Efflux pump inhibition by cyanide m-chlorophenylhydrazone abrogated Etr, but not
tPMP-1r, in the qacA-bearing strain. In synergy assays, exposure of the qacA-bearing strain to tPMP-1 did
not affect the susceptibility of Et (ruling out Et–tPMP-1 cotransport). The following cytoplasmic mem-
brane parameters did not differ significantly between the qacA-bearing and parental strains: contents of
the major phospholipids; asymmetric distributions of the positively charged species, lysyl-phosphotidyl-
glycerol; fatty acid composition; and relative surface charge. Of note, the qacA-bearing strain exhibited
greater membrane fluidity than that of the parental, qacB-, or qacC-bearing strain. In conclusion, among
these families of efflux pumps, only the multidrug transporter encoded by qacA conferred a tPMP-1r
phenotype. These data suggest that qacA-encoded tPMP-1r results from the impact of a specific transporter upon
membrane structure or function unrelated to PMF-dependent peptide efflux.
Mammalian platelets appear to play a critical role in the
innate host defense against the induction and progression of
endovascular infections (6, 7, 22, 39, 43). This host defense
property relates to the capacity of platelets to release a group
of cationic antimicrobial peptides (CAMPs) collectively known
as platelet microbicidal proteins (PMPs) at sites of endovas-
cular damage or infection (39, 43). Both rabbit and human
platelets release functionally and structurally similar PMPs (37,
45) with microbicidal activities in vitro against pathogens that
commonly invade the bloodstream, including Staphylococcus au-
reus (11, 12, 39). To date, the best-characterized PMPs are those
released from platelets following stimulation by the procoagulant
molecule thrombin (i.e., thrombin-induced PMPs [tPMPs]) (11,
19, 20, 40, 45, 46). In humans and animals with catheter-induced
S. aureus bacteremia, strains which are intrinsically susceptible to
tPMPs (tPMPs) in vitro are less likely to cause complicated en-
dovascular infections, such as endocarditis (11, 12).
Previous studies indicated that tPMPs target and permeabilize
the S. aureus cytoplasmic membrane (CM) to initiate their mi-
crobicidal pathway (20, 44). Intracellular targets affecting macro-
molecular synthesis and autolytic enzyme pathways have also
been implicated in the staphylocidal mechanisms of tPMPs (40,
42). However, the precise adaptations by which S. aureus strains
resist the microbicidal activities of tPMPs remain incompletely
defined but appear to include enhanced membrane fluidity (3);
reduced transmembrane potential () (17), and mutations of
genes involved in generating the proton motive force (PMF) (2).
In addition, we recently demonstrated that carriage of plasmids
bearing genes encoding the QacA PMF-dependent transmem-
brane efflux pump specific for cationic compounds was associated
with low-level tPMP resistance (tPMPr) in vitro (21).
The current study was designed to further characterize the
mechanism(s) of tPMPr among strains bearing distinct multi-
drug efflux pumps, especially to delineate whether (i) the active
export of the cationic tPMP was responsible for this phenotype
and (ii) other transmembrane efflux pumps (i.e., qacB and
qacC) also conferred tPMPr in vitro.
(This study was presented in part at the 40th Interscience
Conference on Antimicrobial Agents and Chemotherapy, To-
ronto, Ontario, Canada, 17 to 20 September 2000 [L. I.
Kupferwasser, R. A. Skurray, N. Firth, M. H. Brown, M. R.
Yeaman, R. Prasad, M. Smriti, and A. S. Bayer, abstr. 2288].)
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MATERIALS AND METHODS
Bacterial strains. Table 1 lists the bacterial strains and plasmids used in this
investigation. The parental staphylococcal strain SK982 is plasmid-free and
tPMP-1s in vitro (21). Plasmids carrying either the qacA, qacB, or qacC multidrug
resistance determinants were transferred into SK982 by mixed-culture transfer as
previously described (21). The multidrug transporter-bearing plasmids studied
are members of different staphylococcal plasmid families, including pSK1 from
the pSK1 family; pSK89, a rolling-circle member; pSK108 from the pSK639
family; and pSK21, pSK23, pSK84, and pSK156, which are -lactamase heavy-
metal resistance plasmids (23, 24, 30). pSK5754 is a derivative of pSK1 in which
the qacA gene was replaced with a chloramphenicol resistance (cat) determinant
(14). The Escherichia coli-S. aureus shuttle vector pSK5640 is a derivative of
pSK5630 (13) in which the pUC19 lacZ-MCS fragment has been inserted into
the AatII and PvuII sites. The constructs pSK5672 and pSK5691 are pSK5640-
based plasmids containing a 3.5-kb qacR-qacA BamHI-HindIII fragment and a
1.7-kb qacA BamHI fragment from pSK1, respectively. All strains were kept
frozen at 70°C until thawed and subcultured prior to use.
Preparation of tPMP-1. We focused these studies on tPMP-1 since it is the
best studied and the most abundant of the tPMPs in rabbit platelets. Superna-
tants from thrombin-stimulated rabbit platelets were prepared and tPMP-1 was
subsequently isolated as previously described (45). The bioactivity of tPMP-1
preparations was validated as previously published using a microbiologic assay
with Bacillus subtilis ATCC 6633 as the test organism (37, 45). Bioactive tPMP-1
was kept frozen at 70°C until thawed for use.
tPMP-1 susceptibility assay. Susceptibility profiles of the study constructs to
tPMP-1 were determined by a time-kill assay as previously described (39). Over-
night cultures of the S. aureus isolates were washed twice and suspended in
phosphate-buffered saline. Dilutions of tPMP-1 and S. aureus isolates were
added to polypropylene microculture tubes containing Eagle’s minimal essential
medium (MEM; Irvine Scientific, Santa Ana, CA) to achieve a final tPMP-1
concentration range of 2 to 12 g/ml and a final bacterial inoculum of 103
CFU/ml (i.e., the standard inoculum used for tests of this peptide against S.
aureus [39]). For determination of the percentages of survival, one tube con-
tained only bacteria and MEM and acted as a positive growth control. After 2 h
of incubation at 37°C, suspensions were mixed by vortexing, and 15-l aliquots
were removed from each tube and quantitatively cultured onto blood agar plates.
The proportion of S. aureus cells of each construct that survived a 2-h exposure
to tPMP-1 was expressed as a percentage of the number of CFU of the positive
growth control. All assays were performed in triplicate on two separate days, and
the mean percentage of survival  the standard deviation (SD) was determined.
A tPMP-1r phenotype was defined as 50% survival of the initial inoculum after
a 2-h exposure to tPMP-1 at 37°C. This arbitrary in vitro breakpoint correlates
with an enhanced capacity of such strains to induce and propagate human or
experimental endovascular infections in vivo (11, 22, 39). Data represent the
means (SD) of three independent experiments.
Effect of QacA efflux pump inhibition on S. aureus tPMP-1 resistance. The
qacA-bearing strain SK2355 was exposed either to phosphate-buffered saline
(control) or to 50 M cyanide m-chlorophenylhydrazone (CCCP) for 20 min at
37°C. An additional cell population was exposed to CCCP as described above, in
combination with 20 mM glucose for 10 min to counteract the CCCP effects on
the PMF. After these exposures, the MICs for Et under these various conditions
were determined at a final bacterial inoculum of 106 CFU and a final range of Et
concentrations from 6.25 to 150 g/ml in a microtiter assay. The MIC was
defined as the lowest concentration of Et at which no visible growth was observed
following a 24-h incubation period at 37°C. Data represent the means (SD) of
three independent experiments. In a parallel study, SK2355 cells (103 CFU final
inoculum) were similarly prepared in the presence or absence of 50 M CCCP
with or without 20 mM glucose and then exposed to 2 g/ml tPMP-1 for 2 h in
MEM at 37°C. After tPMP-1 exposures, the percentages of survival were deter-
mined under the different exposure conditions. Since relative tPMP-1r can be
induced by the PMF-lowering actions of CCCP against selected tPMP-1s strains
(2), studies were conducted to distinguish this potential effect from that of
CCCP-induced efflux inhibition in strain SK2355. Thus, we evaluated the tPMP-1
susceptibility profile of parental strain SK982 in the presence or absence of
CCCP (12.5 to 100 mM) using the same assay as outlined above.
Impact of QacA substrate–tPMP-1 coincubations on antistaphylococcal ac-
tivity. Fractional inhibitory concentration (FIC) analysis was carried out in mi-
crotiter plates using 103 CFU of SK2355 cells with combinations of two QacA
substrates, Et and chlorhexidine (Chlx), or tPMP-1. Increasing increments of
each compound (3.125 g/ml to 250 g/ml for Et or Chlx and 1 g/ml to 12 g/ml
for tPMP-1) were combined using the checkerboard procedure (30). Microtiter
plates were incubated for 48 h at 37°C. The Et, Chlx, and tPMP-1 MICs were
determined as described above. The FIC index was calculated as x/MICx 
y/MICy, where x and y represent the lowest concentration of each compound (in
combination) at which there is no growth and MICx and MICy represent the
individual MIC of each compound. FIC indices have been defined as being
indicative of the following: 0.50, synergy; 0.51 to 2.00, additivity; 2.01 to 4.00,
indifference; and	4, antagonism (10, 27, 32). Data represent means (SD) from
three independent experiments.
FA analyses. Fatty acids (FAs) from the total amount of lipids extracted from
the S. aureus constructs were analyzed using gas liquid chromatography after
methyl esterification (courtesy of Microbial ID, Inc., Newark, DE). In brief, 40
mg of bacterial cells was collected and saponified in boiling water with 1 ml of
50% alkaline methanol (15% NaOH) for 30 min. The tubes were cooled, and 2
ml of 45% methanol containing 3 N HCl was added for methylation. The
FA-methyl esters were extracted using a 1:1 mixture of hexane and methyl
tert-butyl ether. The aqueous (lower) phase was discarded, and the organic phase
(containing FAs) was washed with 0.3 N NaOH.
The FA-methyl ester mixtures were separated by ionization analyses (Sherlock
microbial identification system; Microbial ID, Newark, DE). A 25-mm by 0.2-mm
phenyl methyl silicone–fused-silica capillary column with a flame ionization de-
tector and autosampler was used for detection. Each FA-methyl ester composi-
tion was compared to database standards (straight-chained saturated fatty
acids from 9 to 20 carbons in length and five hydroxy acids) using Sherlock
pattern recognition software (Microbial ID, Newark, DE). The unsaturation
profiles as well as the relative compositions of iso- versus anteiso-branched-
chain fatty acids were calculated. All assays were performed a minimum of
two times on separate days.
PL analyses. (i) Extraction, identification, and quantification of PLs. Phos-
pholipids (PLs) were extracted from S. aureus by standard methods (8). Briefly,
cells were grown for 18 h in a brain heart infusion broth, harvested by centrif-
ugation (3,000 
 g, 4°C, 15 min), and washed in buffer A (100 mM potassium
phosphate, 5 mM EDTA, pH 7.2) and then in buffer B (100 mM potassium
phosphate, 600 mM potassium chloride, pH 8.2). Cells (0.6 g [wet weight], 1 

108 cells/ml) were suspended in 3 ml of buffer B and transferred to a 25-ml glass
conical flask and cooled to 4°C with gentle swirling. The suspension was centri-
fuged and the pellet washed with buffer C (200 mM potassium acetate, 600 mM
potassium chloride, pH 4.5) at 4°C.
The cell pellet was then extracted using 2:1 (vol/vol) chloroform-methanol,
followed by washing with 0.9% NaCl to remove nonlipid contaminants (21). The
extracted organic layer was evaporated to dryness under nitrogen and stored at
20°C until analysis. The major PL species, phosphotidylglycerol (PG), cardio-
lipin (CL), and lysyl-phosphotidylglycerol (LPG), were separated by two-dimen-
sional thin-layer chromatography (2D-TLC) using Silica Gel 60 F254 high-per-
formance TLC plates (Merck, Darmstadt, Germany) and subsequently
developed with chloroform-methanol-25% ammonium hydroxide (65:25:6, by
volume) in the vertical orientation and chloroform-acetone-acetic acid-metha-
nol-water (45:16:9:8:4, by volume) in the horizontal orientation, as detailed
previously (9, 15). LPG (positively charged) was identified by ninhydrin staining
(33). PG, CL, and other minor PLs were visualized by exposure of the TLC plate
to iodine vapor. All PLs were purchased from Avanti Polar Lipids, Inc. (Ala-
baster, AL) and used as internal standards to determine the positions of their
spots on 2D-TLC plates.
For quantitative analysis, isolated PLs were individually recovered from TLC
plates and digested at 180°C for 3 h with 0.3 ml of 70% perchloric acid. The
digested samples were incubated with a colorimetric reagent (10% ascorbic
acid, 2.5% ammonium molybdate, 5% perchloric acid [1:1:8, vol/vol/vol]) for
TABLE 1. Bacterial strains and plasmids
Strain Background Plasmid Transporter Reference(s)
SK982 SK982 21
SK2355 SK982 pSK1 QacA 21
SK2416 SK982 pSK108 QacC 23
SK2721 SK982 pSK89 QacC 24
SK2725 SK982 pSK21 QacB 25
SK2727 SK982 pSK23 QacB 30
SK2718 SK982 pSK84 QacB 25
SK2719 SK982 pSK156 QacB 25, 30
SK5791 SK982 pSK5754 14
SK5871 SK982 pSK5640 This study
SK5872 SK982 pSK5672 QacA This study
SK5873 SK982 pSK5691 QacA This study
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2 h at 37°C and quantified spectrophotometrically at an optical density at 660
nm (OD660). The content of each PL species was expressed as a percentage
of the total PL content. All assays were performed a minimum of five times
on separate days.
(ii) LPG distribution. Fluorescamine labeling was carried out by a modifica-
tion of the 2D-TLC protocol described above. After they were harvested and
washed with buffers A and B as described above, cells (0.6 g [wet weight]) were
suspended in 3 ml of buffer B (1 
 108 cells/ml), transferred to a 25-ml glass
conical flask, and cooled to 4°C with gentle swirling. To the cell pellet, 90 l of
fluorescamine solution (0.52 M) in dehydrated dimethyl sulfoxide was added
dropwise, with constant swirling for 30 s. The reaction was stopped by the
addition of 3 ml of 1 M ammonia in 600 mM potassium chloride. The suspension
was centrifuged (3,000 
 g), the pellet was washed four times at 4°C with buffer
C until the supernatant was free of color, and then it was subjected to 2D-TLC
as described above. Fluorescamine labeling of outer-leaflet LPG was detected by
using a UV detector (365-nm excitation). Of note, once bound to LPG, fluores-
camine alters its mobility characteristics and attenuates its ability to be detected
by ninhydrin staining (18). After detection of the fluorescamine-labeled LPG, its
relative content (normalized with respect to total PL and to total LPG) was
quantified by the colorimetric assay described above. All assays were performed
a minimum of five times on separate days.
CM fluidity measurement. CM fluidity was determined by fluorescence polar-
ization using the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene (DPH) as de-
scribed before (3). The protocol for DPH incorporation into target CMs, mea-
surement of fluorescence polarization, and calculation of the degree of
fluorescence polarization index (p.i.) (Biotek model SFM 25 spectrofluorometer;
excitation and emission wavelengths of 360 and 426 nm, respectively) is described
in detail elsewhere (3). The lower the p.i. value, the higher the degree of
membrane fluidity (3). Data represent the means (SD) from three independent
experiments.
Cytochrome c binding. We performed the cytochrome c binding assay accord-
ing to a previously described method (34). In brief, S. aureus cells were grown
overnight and then washed twice with 20 mM MOPS buffer (morpholinepro-
panesulfonic acid, pH 7). The cells were suspended in the same buffer to a final
OD578 of 7. The suspension was incubated with 0.5 mg/ml cytochrome c (95%
purity; Sigma Chemicals, St. Louis, MO) for 10 min in the same buffer and then
centrifuged. The amount of cytochrome c in the supernatant was determined
spectrophotometrically at an OD530 and subtracted from the original cytochrome
c content in solution before bacterial exposure to calculate the percentage of
cytochrome c bound to the cell pellet for each strain. The lower the percentage
of cytochrome c bound to the S. aureus pellet, the more positively charged the S.
aureus cell envelope (34). Data represent the means (SD) from three indepen-
dent experiments.
Statistics. Continuous data were analyzed by Kruskal-Wallis analysis of vari-
ance, with corrections for multiple comparisons where appropriate. A P value of
0.05 was considered significant.
RESULTS
tPMP-1 susceptibility phenotypes. Table 2 depicts the sus-
ceptibility profiles of the study strains to tPMP-1 across a
concentration range of 2 to 12 g/ml. Based on the arbitrary
breakpoint of 50% survival at 2-h exposures, the qacA-bearing
strain SK2355 exhibited low-level resistance over the 2- to
4-g/ml range of tPMP-1. In contrast, the qacB- and qacC-
bearing strains were tPMP-1s across the entire concentration
range, paralleling data for the parental strain, SK982 (Table 2).
These results, irrespective of the plasmid type carrying the
multidrug efflux genes, implied that the differences observed in
tPMP resistance were due solely to the efflux protein. Thus,
one representative strain for each transporter type was used in
subsequent detailed studies (SK2355 qacA, SK2725 qacB, and
SK2416 qacC).
Previous studies using pSK1 and deletion derivatives estab-
lished that the presence of qacA was sufficient to confer a
tPMP-1r phenotype (3, 21). However, qacR, which encodes the
multidrug-binding transcriptional regulator of qacA (5, 14),
was also present on these plasmids. Therefore, to determine if
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qacR directly contributes to tPMP-1r, we constructed pSK5754,
a pSK1 derivative, in which qacA was replaced with a chlor-
amphenicol resistance gene. This plasmid lacked qacA but still
possessed a fully intact qacR determinant (and all other deter-
minants of pSK1) and did not confer tPMP-1r (tested only at 2
g/ml) (Table 2). Additionally, the qacA-negative plasmid vec-
tor-bearing strain SK5871 was tPMP-1s, whereas the qacA-
qacR plasmid-bearing construct (SK5872) and the qacA-alone
plasmid-bearing construct (SK5873) each had approximately
twofold-increased tPMP-1 resistance. These data support the
notion that this is a qacA-specific effect and that the presence
or absence of qacR has no bearing on the observed tPMP-1
resistance phenotype.
Effect of QacA efflux pump inhibition on S. aureus Et and
tPMP-1 susceptibility phenotypes. The QacA membrane pro-
tein uses the PMF to drive substrate export and is inhibitable
by the membrane energy uncoupler CCCP (28). Figure 1 de-
picts the impact of CCCP (in the presence or absence of
glucose) on the Et susceptibility profiles of the qacA-bearing
strain SK2355. As noted, preexposure to CCCP reduced the Et
MIC by approximately fourfold (P  0.05 versus the MIC for
non-CCCP-treated cells), an effect that was reversed by coex-
posures to both CCCP and glucose (Fig. 1). In contrast, CCCP
preexposures had only modest impacts on the tPMP-1r pheno-
type of the strain SK2355 (Fig. 2). In addition, exposing the
plasmid-free parental control strain SK982 to CCCP (12.5 to
100 mM) caused no changes in its tPMP-1s profile (data not
shown).
Impact of QacA substrate–tPMP-1 coincubations on net
antimicrobial activity. Simultaneous exposure of qacA-bearing
strains to two or more substrates microbicidal for the efflux
system should saturate this pump and lead to a reduced efflux
of the individual substrate molecules. This, in turn, should lead
to enhanced inhibition of growth of the organism. This effect
has been confirmed for a number of QacA-substrate combina-
tions (27). To test whether Et and tPMP-1 are cotransported
by QacA, we performed an FIC analysis using combinations of
the two QacA substrates, Et and Chlx, or tPMP-1. The coin-
cubation of Et and Chlx reduced the MICs for each compound
by approximately fourfold compared to those for each com-
pound alone (Fig. 3a) (FIC index, 1; P 0.05). This interaction
was interpreted as additive. In contrast, the coincubation of Et
with tPMP-1 had little effect on the antistaphylococcal activity
of either agent alone (Fig. 3b) (FIC index, 2 [indifference]).
Fatty acid analyses. There were no substantive differences
observed in total fatty acid contents, unsaturation distribu-
tions, iso- or anteiso-branched-chain fatty acid contents, or
ratios between the study strains (data not shown).
Phospholipid analyses. Fluorescamine, a fluorescent probe
which specifically labels CM surface-exposed (outer-leaflet)
positively charged amino PLs was used to assay the CM LPG
distribution (2, 15). For both the parental SK982 and qacA-
bearing SK2355 strains, PG was the predominant CM phos-
FIG. 1. Effects of efflux pump inhibition by CCCP upon the Et
MICs (SD) and potential reversal by coincubation with glucose in
SK2355. See the text for details.
FIG. 2. Effect of efflux pump inhibition by CCCP on tPMP-1 sus-
ceptibility in SK2355 (percentage of survival  SD after 2 h of incu-
bation) and potential reversal by glucose coincubation. See the text for
details.
FIG. 3. Et-Chlx and Et–tPMP-1 checkerboard synergy assays with
SK2355. Impact of Et and Chlx alone and in combination (comb) (a)
and of Et and tPMP-1 alone and in combination (b) on the single-
agent MICs. See the text for details.
VOL. 50, 2006 QacA AND tPMP RESISTANCE IN S. AUREUS 2451
 o
n
 April 30, 2012 by FLINDERS UNIVERSITY O
F SO
UTH AUSTRALIA
http://aac.asm
.org/
D
ow
nloaded from
 
Archived at Flinders University: dspace.flinders.edu.au
pholipid (67% for each strain). This mirrors data generated
from our laboratory using other genetic background strains of
S. aureus (41). There were no substantial differences in the
relative proportions among the three major membrane phos-
pholipids, PG, CL (7% for each strain), and LPG (23% for
each strain), in a comparison of the parental strain, SK982,
with qacA-bearing SK2355. Moreover, the distributions of
LPG within the outer versus the inner CM leaflets did not
differ between strains (5 to 6% of the total LPG was distri-
buted to the outer CM leaflet).
CM fluidity measurements. DPH is a probe that localizes in
the hydrophobic core of the lipid bilayer and is highly fluores-
cent when bound therein. Fluorescence polarization studies
using DPH revealed that the CMs of the qacA-bearing strain
SK2355 (p.i., 0.293  0.01) were more fluid than those of the
parental strain (p.i., 0.31  0.13) and those of the strains
carrying qacB- and qacC-containing plasmids (p.i., 0.315 
0.02 and 0.308  0.01, respectively).
Cytochrome c binding. Cytochrome c is a cationic protein
derived from equine heart. It has been used previously to
estimate the relative surface charge of the cell envelope of
isogenic S. aureus strain pairs (34). Cytochrome c binding as-
says showed that there were no differences in levels of binding
to the cell surface of the parental strain SK9892, SK2725, or the
tPMP-1r strain SK2355 (28%  3%, 31%  14%, and 30% 
4%, respectively). Although the binding of cytochrome c to the
qacC-bearing strain SK2416 was somewhat higher than that of
the other three constructs (46%  14%), this difference did
not reach statistical significance.
DISCUSSION
We have previously shown that the capacity of S. aureus
strains to acquire low-level resistance to tPMP-1 enables the
organism to persist in both experimental infections and human
endovascular infections (1, 6, 7, 11). Five mechanisms have
been described which are associated with reduced in vitro
susceptibility to tPMPs in S. aureus. (i) Small-colony variants,
either gentamicin-induced or created by the mutagenesis of
respiratory chain components (e.g., the hemB or menD locus)
(19), maintain a substantially lowered  than parental strains
due to such electron transport chain defects (19, 20). (ii) Vari-
ants selected following serial passages of tPMP-1r S. aureus
strains in this peptide (43), like small-colony variants, exhibit a
diminished  (A. S. Bayer, M. R. Yeaman, H.-G. Sahl, D.
Brar, and R. A. Proctor, Abstr. 97th Gen. Meet. Am. Soc.
Microbiol., abstr. A-106, p. 19, 1997). (iii) Strains with trans-
poson disruptions in the complex I enzyme function result in
the defective generation of the . We have recently shown
that mutations within the snoA-snoG operon (which encodes
an NADH oxidoreductase) render such strains relatively
tPMP-1r (2). Importantly for CAMPs, a threshold  appears
to be critical for their interactions with target microbial mem-
branes. Thus, the diminished  observed in these three strain
types likely contributes to their tPMP-1r phenotype. (iv)
Strains showing relative increases in cell surface positive
charge, as demonstrated by Peschel et al. (33, 34), have cell
membranes and cell walls that contain high proportions of
positively charged phospholipids and teichoic acids species,
respectively. This renders such strains relatively resistant to
killing by a number of CAMPs, including tPMP-1. Lysinylation
of phosphotidylglycerol and D-alanylation of teichoic acid ap-
pear to be responsible for this phenotype. These data suggest
that the charge-based surface repulsion of CAMPs by a less
negatively charged surface envelope could contribute to
CAMP resistance (33, 34). (v) We also recently showed that S.
aureus strains carrying plasmid determinants (e.g., pSK1) en-
coding the PMF-dependent, multidrug export pump QacA of
the major facilitator superfamily of transport proteins also
exhibit reduced susceptibility to tPMP-1 in vitro, compared to
that of the isogenic parental or a qacA mutant construct (21).
The current study was designed to further investigate the
mechanisms by which qacA carriage confers relative tPMP-1
resistance and whether this phenotype is specific for qacA or is
a general mechanism conferred by the presence of other mul-
tidrug exporter proteins.
Several interesting observations emanated from this study.
First, among the three multidrug export proteins QacA, QacB,
and QacC, only QacA was associated with low-level tPMP-1
resistance at multiple peptide concentrations. These three
multidrug export proteins all confer resistance to monovalent
cationic chemicals, for example Et. In addition, QacA confers
resistance to bivalent cationic compounds, such as Chlx (24,
27). In fact, studies have shown that QacA mediates resistance
to more than 30 cationic, lipophilic antimicrobials belonging to
12 distinct chemical families, although no resistance to triva-
lent cations or to anionic compounds has been observed (5, 27,
28). QacC is a small-membrane protein that belongs to a sep-
arate family of transport proteins, the small, multidrug resis-
tance family (31), and shares no structural homology to QacA
or QacB. In contrast, the QacA and QacB export proteins are
highly related; there are only seven amino acid differences
between them, and one of these differences, at position 323, is
responsible for the resistance to bivalent cations demonstrated
by QacA but not QacB (29). Second, resistance to CAMPs via
active efflux has been described to exist in a number of bacte-
ria. For example, in Yersinia enterocolitica, the Ros system,
composed of RosA and RosB, a major facilitator superfamily
multidrug export protein and a potassium efflux protein, re-
spectively, mediates resistance to CAMPs using an energy-
dependent process (4). Similarly, in Neisseria spp., Shafer et al.
and Tzeng et al. have demonstrated the presence of the PMF-
driven Mtr multidrug efflux system which modulates suscepti-
bility to a range of CAMPs (36, 38). However, despite the fact
that tPMP-1 is a lysine-rich cationic peptide (net charge, 5
[46]), making it a potential candidate for export by QacA, two
lines of evidence reported here are against this hypothesis. (i)
Interference with QacA pump function via the PMF inhibitor
CCCP did not significantly impact the tPMP-1 susceptibility
phenotype and (ii) coincubation of Et and tPMP-1 in the
qacA-bearing strain did not substantially affect the in vitro
activity of either agent, suggesting that QacA-mediated co-
transport of these two antimicrobials did not occur. Further-
more, CCCP might induce a relative tPMP-1r phenotype by its
nonspecific reduction in the PMF, which might be compen-
sated for by a putative QacA-mediated tPMP-1 efflux in strain
SK2355. Therefore, we evaluated the impacts of CCCP on the
parental strain’s (SK982) tPMP-1 susceptibility profile. The
finding that CCCP did not affect the tPMP-1 susceptibility of
strain SK982 strongly suggests that the QacA-associated
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tPMP-1r phenotype observed in SK2355 is not attributable to a
combined specific efflux and a nonspecific PMF reduction.
As the cytoplasmic membrane is a principal target for initi-
ating the staphylocidal pathway of tPMP-1, we carried out
several analyses of the membrane structure and function in a
comparison of the parental strain with strains expressing the
three different multidrug export pumps. Only the qacA-bearing
strain exhibited an increase in membrane fluidity compared to
that of the other members of this isogenic strain set. Of note,
enhanced membrane fluidity has been a consistent feature of
several other tPMP-1r S. aureus strains, including the above-
mentioned transposon and serial-passage variants. We recently
studied the potential biophysical mechanisms of increased
membrane fluidity in the transposon-derived sno mutant of S.
aureus (K. Mukhopadhyay, W. Whitmire, J. Molden, Y. Q.
Xiong, A. Peschel, P. McNamara, R. A. Procotor, J. Adler-
Moore, M. R. Yeaman, and A. S. Bayer, Abstr. 105th Gen.
Meet. Am. Soc. Microbiol., abstr. A-002, p. 1, 2005). In this
construct, the basis for enhanced fluidity was related to an
increased proportion of shorter acyl chain length fatty acids
and a shift in branched-chain fatty acids from iso-branched to
anteiso-branched species (16). Of particular importance,
more-fluid membranes tend to leak protons, with a resulting
decrease in  (17). Since a threshold  appears to be re-
quired for the optimal microbicidal efficacy of tPMP-1 (20, 44),
this is one potential explanation for the linkage between en-
hanced membrane fluidity and relative tPMP-1 resistance. In
addition, extremes of CM fluidity or rigidity are likely to im-
pact the interactions of CAMPs with the target membrane (26,
41). It should be emphasized that relatively small changes in
CM characteristics (such as fluidity) have a major impact upon
interactions with CAMPs (35). Of note, we could not detect
any substantial differences in membrane fatty acid composition
in the current stain set.
An additional mechanism by which CM structure may influ-
ence tPMP-1 susceptibility profiles relates to its PL content
and distribution (17). Several laboratories have shown that the
overall content of the unique positively charged membrane
phospholipid species, LPG, may substantially affect the overall
surface charge of the organism. Peschel et al. (33, 34) have
recently shown that knockouts of the genes responsible for the
lysinylation of PG (mprF) or the D-alanylation of cell wall
teichoic acid (dltA) render the surface envelope of such con-
structs more negatively charged. This enables a number of
CAMPs to bind to the surfaces of these strains more avidly,
making them more peptide susceptible in vitro. In recent stud-
ies, we confirmed that the transposon-derived tPMP-1r snoD
mutant displayed a significantly increased proportion of outer-
leaflet-localized LPG compared to that of its tPMP-1s parental
strain. These characteristics provided the mutant with an en-
hanced repulsive cell surface toward the cationic molecule,
cytochrome c, and perhaps tPMP-1. Similar analyses in the
current study could not confirm either the increased overall
LPG content or the enhanced outer-leaflet LPG asymmetry for
the qacA-bearing construct.
In summary, our investigations delineate a strong correla-
tion between the presence of the QacA transmembrane efflux
pump and a tPMP-1r phenotype that is not explicable by the
transport of this cationic peptide. Ongoing studies in our lab-
oratories are focusing upon (i) analyses of tPMP-1 binding
among these distinct constructs and (ii) investigations to define
the mechanism(s) of enhanced membrane fluidity in tPMP-1r
strains in the context of qacA carriage.
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